Profile for Vertex Pharmaceuticals Incorporated (VRTX)

$ 226.70   -3.60 (-1.56%) Volume: 1.86m 4:00 PM EST Dec 2, 2020
After Hours:  $ 226.72   0.02 (+0.01%) Volume: 121.23k 7:46 PM EST Dec 2, 2020
Business Description:
Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.
Address: 50 Northern Avenue, Boston, MA, US, 02210
Telephone: +1 617 341-6100 Website:
Facsimile: N/A Email: [email protected]
CEO: Reshma Kewalramani
Employees: 3,000 Market Cap: 58.95b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 875320
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)